Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Sientra, Inc. (SIEN : NSDQ)
 
 • Company Description   
Sientra, Inc. is a medical aesthetics company. The Company offers plastic surgery implantable devices for cosmetic and reconstructive surgery, including Breast Implants, Tissue Expanders, Body Contouring, Implants and Specialty Products. Sentra's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. It also offers a range of other aesthetic and specialty products. Sientra, Inc. is headquartered in Santa Barbara, California.

Number of Employees: 319

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.19 Daily Weekly Monthly
20 Day Moving Average: 937,337 shares
Shares Outstanding: 62.64 (millions)
Market Capitalization: $74.54 (millions)
Beta: 2.11
52 Week High: $9.14
52 Week Low: $1.15
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -40.20% -34.72%
12 Week -57.95% -54.55%
Year To Date -67.57% -61.59%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
420 SOUTH FAIRVIEW AVENUE SUITE 200
-
SANTA BARBARA,CA 93117
USA
ph: 805-562-3500
fax: 805-562-8401
ir@sientra.com http://www.sientra.com
 
 • General Corporate Information   
Officers
ronald Menezes - Chief Executive Officer;President
Caroline Van Hove - Executive Chair of the Sientra; Inc. Board
Andrew C. Schmidt - Chief Financial Officer and Treasurer
Nori ebersole - Director
Mary M. Fisher - Director

Peer Information
Sientra, Inc. (ABMD)
Sientra, Inc. (DMDS)
Sientra, Inc. (CPWY.)
Sientra, Inc. (EQUR)
Sientra, Inc. (ECIA)
Sientra, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 82621J105
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/09/22
Share - Related Items
Shares Outstanding: 62.64
Most Recent Split Date: (:1)
Beta: 2.11
Market Capitalization: $74.54 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.22 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.88 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/09/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.69
Price/Cash Flow: -
Price / Sales: 0.89
EPS Growth
vs. Year Ago Period: -190.00%
vs. Previous Quarter: -7.41%
Sales Growth
vs. Year Ago Period: -7.91%
vs. Previous Quarter: -5.52%
ROE
03/31/22 - -558.76
12/31/21 - -865.36
09/30/21 - -
ROA
03/31/22 - -49.13
12/31/21 - -42.18
09/30/21 - -45.72
Current Ratio
03/31/22 - -
12/31/21 - 1.76
09/30/21 - 2.05
Quick Ratio
03/31/22 - -
12/31/21 - 1.10
09/30/21 - 1.33
Operating Margin
03/31/22 - -112.82
12/31/21 - -95.53
09/30/21 - -99.41
Net Margin
03/31/22 - -71.61
12/31/21 - -112.89
09/30/21 - -118.93
Pre-Tax Margin
03/31/22 - -
12/31/21 - -77.46
09/30/21 - -58.99
Book Value
03/31/22 - -
12/31/21 - 0.70
09/30/21 - 0.70
Inventory Turnover
03/31/22 - -
12/31/21 - 0.73
09/30/21 - 0.74
Debt-to-Equity
03/31/22 - -
12/31/21 - 1.53
09/30/21 - 1.51
Debt-to-Capital
03/31/22 - -
12/31/21 - 60.44
09/30/21 - 60.13
 

Powered by Zacks Investment Research ©